Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2745 USD | +5.17% | -3.68% | +14.71% |
Apr. 01 | Transcript : Yield10 Bioscience, Inc., Q4 2023 Earnings Call, Apr 01, 2024 | |
Apr. 01 | Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Business Summary
Number of employees: 29
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Specialty Oils and Niche Crops
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -86.67% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -86.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 07-12-31 |
Kristi D. Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 96-12-31 |
Lynne Brum
IRC | Investor Relations Contact | 60 | 11-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 06-09-30 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 17-03-01 |
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Anthony Sinskey
FOU | Founder | 83 | 92-05-31 |
Sherri Brown
BRD | Director/Board Member | 63 | 20-02-10 |
Willie Loh
BRD | Director/Board Member | 69 | 22-10-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,401,706 | 13,460,010 ( 87.39 %) | 0 | 87.39 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.71% | 4.02M | |
+2.17% | 42.11B | |
+49.22% | 40.08B | |
+7.77% | 40B | |
-11.32% | 26.87B | |
+6.25% | 24.58B | |
-22.46% | 18.44B | |
+1.48% | 11.94B | |
+18.58% | 11.66B | |
+8.03% | 11.01B |
- Stock Market
- Equities
- YTEN Stock
- Company Yield10 Bioscience, Inc.